Effect of high dose vitamin D in patients with ischemic stroke

Phase 2

Recruiting

• Conditions: ischemic stroke.; ischemic stroke; 163.9

• Registration Number: IRCT20120703010178N24
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients with Ischemic Stroke
Patients over 16

Exclusion Criteria

Myocardial infarction in past 30 days
Vitamin D level more than 30ng/ml

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in the neuron-specific enolase between two arms of the study. Timepoint: Before intervention and 3 days after intervention. Method of measurement: EIA kit for the measurement of neuron-specific enolase.

Secondary Outcome Measures

Name	Time	Method
ational Institutes of Health Stroke Scale. Timepoint: Daily until hospital discharge. Method of measurement: National Institutes of Health Stroke Scale questioner.;Barthel index. Timepoint: 3 months after stroke. Method of measurement: Barthel index questioner.